Stocks
AstraZeneca PLCAZN
NYSEHealthcarePharmaceuticals$189.90-1.35%
A global biopharmaceutical company focused on the development and commercialization of prescription medicines, with core franchises in oncology, cardiovascular, renal and metabolism, respiratory, immunology, and rare diseases. Revenue is driven by a portfolio of blockbuster therapies and an extensive late-stage pipeline, making clinical trial data, regulatory approvals, and patent expirations key catalysts for investors. With a significant international footprint and exposure to pricing and reimbursement trends, it is closely watched for pipeline execution and capital allocation decisions.
Market Cap: $294.4B52W Range: $122.48 – $212.71
Congressional Interest in AstraZeneca PLC (AZN)
22 members of Congress have disclosed 50 trades in AstraZeneca PLC (AZN), a Healthcare company. The buy/sell breakdown shows 23 purchases versus 26 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
22
Buys
23
Sells
26
Who in Congress Is Trading AZN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-31 | Alan Armstrong | buy | $1K – $15K |
| 2026-03-30 | Alan Armstrong | buy | $15K – $50K |